ESPR vs MSI · rev $332.3M vs P/E 33, rev $11.68B
Esperion Therapeutics Inc (ESPR) versus Motorola Solutions Inc (MSI) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Motorola Solutions Inc (MSI) is a communication equipment company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported MSI revenue for 2025-12-31 was $11.68B. Net income was $2.15B. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
ESPR currently screens at market cap $816.9M. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
Not investment advice. Open the ESPR and MSI stock pages for the full models.
Not investment advice.